Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.200
+0.100 (4.76%)
Apr 17, 2026, 4:28 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 12.05 million as of April 17, 2026. Its market cap has increased by 188.04% in one year.
Market Cap
12.05M
Enterprise Value
11.77M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 12.05M, a decrease of -64.17%. That is a compound annual growth rate of -21.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.05M | 32.00% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 21.59M |
| Fusion Antibodies | 18.13M |
| Oxford BioDynamics | 9.23M |
| Cizzle Biotechnology Holdings | 8.52M |
| Futura Medical | 6.73M |
| IXICO | 6.60M |